It is estimated that more than 50% of women experience at least one urinary tract infection, or cystitis, over the course of their life. Every year, 15% of women have a urinary tract infection and 25% of them are recurring, having a major impact on these women’s quality of life and their health.
Every year in France alone, this pathology leads to 5 million medical consultations, resulting in the diagnosis of an acute urinary tract infection. It is also estimated that one million women in France suffer from recurring cystitis. These illnesses are therefore a public health concern for economic reasons, due to the direct and indirect medical costs incurred (prescriptions, sick leave), as well as for ecological reasons, as the repeated prescription of antibiotics contributes to the risk that resistant bacteria strains will emerge.